Dr Jeffrey David Powell, DO | |
3800 Sierra Cir, Center Valley, PA 18034-8476 | |
(484) 664-2483 | |
Not Available |
Full Name | Dr Jeffrey David Powell |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 11 Years |
Location | 3800 Sierra Cir, Center Valley, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871921551 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Lehigh Valley Hospital | Allentown, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Anesthesiologists can significantly reduce loss of muscle strength in ACL knee surgery patients using a new pain management technique, a new study has found.
Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.
Researchers from the Cochrane Collaboration research group have reviewed 54 studies in order to assess just how well specialist asthma equipment worked; the studies involved over 3,000 people.
› Verified 3 days ago
Entity Name | Geisinger Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Anesthesiologists can significantly reduce loss of muscle strength in ACL knee surgery patients using a new pain management technique, a new study has found.
Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.
Researchers from the Cochrane Collaboration research group have reviewed 54 studies in order to assess just how well specialist asthma equipment worked; the studies involved over 3,000 people.
› Verified 3 days ago
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Anesthesiologists can significantly reduce loss of muscle strength in ACL knee surgery patients using a new pain management technique, a new study has found.
Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.
Researchers from the Cochrane Collaboration research group have reviewed 54 studies in order to assess just how well specialist asthma equipment worked; the studies involved over 3,000 people.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey David Powell, DO 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Jeffrey David Powell, DO 3800 Sierra Cir, Center Valley, PA 18034-8476 Ph: (484) 664-2483 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Anesthesiologists can significantly reduce loss of muscle strength in ACL knee surgery patients using a new pain management technique, a new study has found.
Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.
Researchers from the Cochrane Collaboration research group have reviewed 54 studies in order to assess just how well specialist asthma equipment worked; the studies involved over 3,000 people.
› Verified 3 days ago
Clark Anthony Veet, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3800 Sierra Cir Ste 115, Center Valley, PA 18034 Phone: 484-664-2480 Fax: 484-664-2483 | |
Dr. Remy W Mimms, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5445 Lanark Rd Fl 3, Center Valley, PA 18034 Phone: 484-526-7300 Fax: 866-449-5832 | |
Bankim Bhatt, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5445 Lanark Rd Ste 300, Center Valley, PA 18034 Phone: 484-526-7300 Fax: 866-449-5832 | |
Renee E Amori, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5445 Lanark Rd Fl 3, Center Valley, PA 18034 Phone: 484-526-7300 Fax: 866-449-5832 | |
Santh Venkat Santosh Silparshetty, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5445 Lanark Rd Fl 3, Center Valley, PA 18034 Phone: 484-526-7300 Fax: 866-449-5832 | |
Dr. Thomas E Young, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4025 W Hopewell Rd, Center Valley, PA 18034 Phone: 610-798-7546 | |
Sara Choudhry, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5445 Lanark Rd Ste 300, Center Valley, PA 18034 Phone: 484-526-7300 Fax: 866-449-5832 |